merged_drug-prices-medicare.txt
<question_number>1</question_number>
<answer>The $2,000 annual cap on patient costs for drugs taken at home will go into effect in 2024, while the new negotiated prices will take effect in 2026.</answer>
<question_number>2</question_number>
<answer>The Project 2025 playbook argues that the drug price negotiation program should be repealed, which would likely result in a decrease in the number of drugs negotiated by the federal government.</answer>
<question_number>3</question_number>
<answer>Vice President Kamala Harris cast the tiebreaking vote for the legislation that delivered the drug price negotiation program, and she has focused some of her early presidential campaign on the Biden administration's drug pricing reforms, including the cap on monthly insulin costs for Medicare recipients.</answer>
<question_number>4</question_number>
<answer>N/A</answer>
<question_number>5</question_number>
<answer>$730</answer>
<question_number>6</question_number>
<answer>AbbVie and Johnson & Johnson</answer>
<question_number>7</question_number>
<answer>Enbrel</answer>
<question_number>8</question_number>
<answer>75.5%</answer>
<question_number>9</question_number>
<answer>$117</answer>
<question_number>10</question_number>
<answer>$10,264</answer>
